Article
17 Apr 2026
Getting Form 483 Responses Right: FDA’s March 2026 Draft Guidance Explained
AUTHORS CONTENT
Article
23 Mar 2026
BIOSECURE And The Shift To Secure Biotech Supply Chains
Article
19 Mar 2026
FDA Proposes New Evidence Playbook For Individualized Therapies
Article
03 Mar 2026
FDA's Makary Declares Upcoming Crackdown On GLP-1 Claims, Importation
Article
10 Feb 2026
AdvaMed Modernizes Its Code Of Ethics For The Digital Era
Article
23 Jan 2026
Rolling Forward: Cannabis Reform Takes A New Turn
Article
23 Jan 2026
TEMPO Pilot Enrollment Begins: The Race For Digital Health Access Is On
Article
22 Jan 2026
GLP-1 Coverage Expansion Under Medicare: What Digital Health Companies Need To Know
Article
21 Jan 2026
FDA's New AI And Wearables Guidance
Article
20 Jan 2026
FDA Loosens The Reins: New AI And Wearables Guidance